Meseclazone
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | none |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | 29053-27-8 |
PubChem (CID) | 34445 |
ChemSpider | 31698 |
UNII | 51KFT71THG |
KEGG | D04941 |
ChEMBL | CHEMBL2104738 |
Chemical and physical data | |
Formula | C11H10ClNO3 |
Molar mass | 239.66 g/mol |
3D model (Jmol) | Interactive image |
|
Meseclazone (W-2395), also known as 2-methylseclazone, is a non-steroidal anti-inflammatory drug (NSAID) developed in the 1970s.[1][2] It functions as a prodrug to the 5-chloro derivative of salicyclic acid.[2] It was never marketed on account of toxicity issues, namely pertaining to the liver.[2]
See also
References
- ↑ Dictionary of organic compounds. London: Chapman & Hall. 1996. ISBN 0-412-54090-8.
- 1 2 3 Rainsford, K. D. (2004). Aspirin and related drugs. Washington, DC: Taylor & Francis. ISBN 0-7484-0885-1.
This article is issued from Wikipedia - version of the 10/16/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.